Albaconazole tablet 400mg + Albaconazole 100mg capsules, then albaconazole 400mg tablet

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
32
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Onychomycosis

Conditions

Onychomycosis

Trial Timeline

Nov 23, 2009 โ†’ Jan 20, 2010

About Albaconazole tablet 400mg + Albaconazole 100mg capsules, then albaconazole 400mg tablet

Albaconazole tablet 400mg + Albaconazole 100mg capsules, then albaconazole 400mg tablet is a phase 1 stage product being developed by GSK plc for Onychomycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01039883. Target conditions include Onychomycosis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01039883Phase 1Completed